The influence of prebiotic arabinoxylan oligosaccharides on microbiota derived uremic retention solutes in patients with chronic kidney disease: A randomized controlled trial

PLoS ONE

Volumn 11, Issue 4, 2016, Pages

  Poesen, Ruben ^a   Evenepoel, Pieter ^a   De Loor, Henriette ^a   Delcour, Jan A ^b,c   Courtin, Christophe M ^b,c   Kuypers, Dirk ^a   Augustijns, Patrick ^d   Verbeke, Kristin ^c,e   Meijers, Björn ^a  

^a UNIVERSITY HOSPITALS LEUVEN   (Belgium)

^b UNIVERSITY OF LEUVEN   (Belgium)

^c LEUVEN FOOD SCIENCE AND NUTRITION RESEARCH CENTRE LFORCE   (Belgium)

^d DEPARTMENT OF PHARMACEUTICAL AND PHARMACOLOGICAL SCIENCES   (Belgium)

^e UNIVERSITY OF LEUVEN   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; AMINO ACID; ARABINOXYLAN OLIGOSACCHARIDE; GLUCURONIDE; INDICAN; MALTODEXTRIN; PARA CRESYL GLUCURONIDE; PARA CRESYL SULFATE; PHENYLACETYLGLUTAMINE; PLACEBO; PREBIOTIC AGENT; SULFATE; TRIMETHYLAMINE OXIDE; UNCLASSIFIED DRUG; ARABINOXYLAN; OLIGOSACCHARIDE; UREA; XYLAN;

AGED; ARTICLE; BLOOD LEVEL; CHRONIC KIDNEY DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; CROSSOVER PROCEDURE; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; FEMALE; FLATULENCE; GLOMERULUS FILTRATION RATE; HUMAN; INSULIN RESISTANCE; LIQUID CHROMATOGRAPHY; MALE; MEDICATION COMPLIANCE; MICROFLORA; PATIENT COMPLIANCE; RANDOMIZED CONTROLLED TRIAL; TANDEM MASS SPECTROMETRY; UREMIA; UREMIC RETENTION SOLUTE; URINE LEVEL; DRUG EFFECTS; HEMODIAFILTRATION; HEMODIALYSIS; METABOLISM; MICROBIOLOGY; RENAL INSUFFICIENCY, CHRONIC;

AGED; CROSS-OVER STUDIES; DOUBLE-BLIND METHOD; FEMALE; HEMODIAFILTRATION; HUMANS; MALE; MICROBIOTA; OLIGOSACCHARIDES; PREBIOTICS; RENAL DIALYSIS; RENAL INSUFFICIENCY, CHRONIC; UREA; UREMIA; XYLANS;

EID: 84964862981     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0153893     Document Type: Article

References (28)

1. Meijers B, Glorieux G, Poesen R, Bakker SJ. Nonextracorporeal methods for decreasing uremic solute concentration: A future way to go? Semin Nephrol 2014 Mar; 34(2):228-43. doi: 10.1016/j.semnephrol.2014.02.012 PMID: 24780475.
2. Meyer TW, Hostetter TH. Uremia. N Engl J Med 2007 Sep 27; 357(13):1316-25. PMID: 17898101.
3. Aronov PA, Luo FJ, Plummer NS, Quan Z, Holmes S, Hostetter TH, et al. Colonic contribution to uremic solutes. J Am Soc Nephrol 2011 Sep; 22(9):1769-76. doi: 10.1681/ASN.2010121220 PMID: 21784895.
4. Meyer TW, Hostetter TH. Uremic solutes from colon microbes. Kidney Int 2012 May; 81(10):949-54. doi: 10.1038/ki.2011.504 PMID: 22318422.
5. Bammens B, Evenepoel P, Keuleers H, Verbeke K, Vanrenterghem Y. Free serum concentrations of the protein-bound retention solute p-cresol predict mortality in hemodialysis patients. Kidney Int 2006 Mar; 69(6):1081-7. PMID: 16421516.
6. Liabeuf S, Barreto DV, Barreto FC, Meert N, Glorieux G, Schepers E, et al. Free p-cresylsulphate is a predictor of mortality in patients at different stages of chronic kidney disease. Nephrol Dial Transplant 2010 Apr; 25(4):1183-91. doi: 10.1093/ndt/gfp592 PMID: 19914995.
7. Meijers BK, Bammens B, De Moor B, Verbeke K, Vanrenterghem Y, Evenepoel P. Free p-cresol is associated with cardiovascular disease in hemodialysis patients. Kidney Int 2008 May; 73(10):1174- 80. doi: 10.1038/ki.2008.31 PMID: 18305466.
8. Meijers BK, Claes K, Bammens B, de Loor H, Viaene L, Verbeke K, et al. p-Cresol and cardiovascular risk in mild- To-moderate kidney disease. Clin J Am Soc Nephrol 2010 Jul; 5(7):1182-9. doi: 10.2215/CJN.07971109 PMID: 20430946.
9. Barreto FC, Barreto DV, Liabeuf S, Meert N, Glorieux G, Temmar M, et al. Serum indoxyl sulfate is associated with vascular disease and mortality in chronic kidney disease patients. Clin J Am Soc Nephrol 2009 Oct; 4(10):1551-8. doi: 10.2215/CJN.03980609 PMID: 19696217.
10. Wu IW, Hsu KH, Lee CC, Sun CY, Hsu HJ, Tsai CJ, et al. p-Cresyl sulphate and indoxyl sulphate predict progression of chronic kidney disease. Nephrol Dial Transplant 2011 Mar; 26(3):938-47. doi: 10. 1093/ndt/gfq580 PMID: 20884620.
11. Meert N, Schepers E, Glorieux G, Van LM, Goeman JL, WaterloosMA, et al. Novelmethod for simultaneous determination of p-cresylsulphate and p-cresylglucuronide: clinical data and pathophysiological implications. Nephrol Dial Transplant 2012 Jun; 27(6):2388-96. doi: 10.1093/ndt/gfr672 PMID: 22167586.
12. Tang WH, Wang Z, Kennedy DJ, Wu Y, Buffa JA, Agatisa-Boyle B, et al. Gut microbiota-dependent trimethylamine N-oxide (TMAO) pathway contributes to both development of renal insufficiency and mortality risk in chronic kidney disease. Circ Res 2015 Jan 30; 116(3):448-55. doi: 10.1161/CIRCRESAHA.116.305360 PMID: 25599331.
13. Stubbs JR, House JA, Ocque AJ, Zhang S, Johnson C, Kimber C, et al. Serum Trimethylamine-NOxide is Elevated in CKD and Correlates with Coronary Atherosclerosis Burden. J Am Soc Nephrol 2015 [Epub ahead of print].
14. Shafi T, Meyer TW, Hostetter TH, Melamed ML, Parekh RS, Hwang S, et al. Free Levels of Selected Organic Solutes and Cardiovascular Morbidity and Mortality in Hemodialysis Patients: Results from the Retained Organic Solutes and Clinical Outcomes (ROSCO) Investigators. PLoS One 2015; 10(5): E0126048. doi: 10.1371/journal.pone.0126048 PMID: 25938230.
15. Poesen R, Meijers B, Evenepoel P. The Colon: An Overlooked Site for Therapeutics in Dialysis Patients. Semin Dial 2013 Mar 4; 26:323-32. doi: 10.1111/sdi.12082 PMID: 23458264.
16. Roberfroid M, Gibson GR, Hoyles L, McCartney AL, Rastall R, Rowland I, et al. Prebiotic effects: metabolic and health benefits. Br J Nutr 2010 Aug; 104 Suppl 2:S1-63. doi: 10.1017/S0007114510003363 PMID: 20920376.
17. Meijers BK, De Preter V, Verbeke K, Vanrenterghem Y, Evenepoel P. p-Cresyl sulfate serum concentrations in haemodialysis patients are reduced by the prebiotic oligofructose-enriched inulin. Nephrol Dial Transplant 2010 Jan; 25(1):219-24. doi: 10.1093/ndt/gfp414 PMID: 19692415.
18. Sirich TL, Plummer NS, Gardner CD, Hostetter TH, Meyer TW. Effect of increasing dietary fiber on plasma levels of colon-derived solutes in hemodialysis patients. Clin J Am Soc Nephrol 2014 Sep 5; 9 (9):1603-10. doi: 10.2215/CJN.00490114 PMID: 25147155.
19. Koppe L, Pillon NJ, Vella RE, Croze ML, Pelletier CC, Chambert S, et al. p-Cresyl sulfate promotes insulin resistance associated with CKD. J Am Soc Nephrol 2013 Jan; 24(1):88-99. doi: 10.1681/ASN. 2012050503 PMID: 23274953.
20. Broekaert WF, Courtin CM, Verbeke K, Van de Wiele T, VerstraeteW, Delcour JA. Prebiotic and other health-related effects of cereal-derived arabinoxylans, arabinoxylan-oligosaccharides, and xylooligosaccharides. Crit Rev Food Sci Nutr 2011 Feb; 51(2):178-94. doi: 10.1080/10408390903044768 PMID: 21328111.
21. Cloetens L, Broekaert WF, Delaedt Y, Ollevier F, Courtin CM, Delcour JA, et al. Tolerance of arabinoxylan- oligosaccharides and their prebiotic activity in healthy subjects: A randomised, placebo-controlled cross-over study. Br J Nutr 2010 Mar; 103(5):703-13. doi: 10.1017/S0007114509992248 PMID: 20003568.
22. Damen B, Cloetens L, Broekaert WF, Francois I, Lescroart O, Trogh I, et al. Consumption of breads containing in situ-produced arabinoxylan oligosaccharides alters gastrointestinal effects in healthy volunteers. J Nutr 2012 Mar; 142(3):470-7. doi: 10.3945/jn.111.146464 PMID: 22298569.
23. Francois IE, Lescroart O, Veraverbeke WS, Marzorati M, Possemiers S, Evenepoel P, et al. Effects of a wheat bran extract containing arabinoxylan oligosaccharides on gastrointestinal health parameters in healthy adult human volunteers: A double-blind, randomised, placebo-controlled, cross-over trial. Br J Nutr 2012 Feb 28;1-14.
24. Francois IE, Lescroart O, Veraverbeke WS, Marzorati M, Possemiers S, Hamer H, et al. Effects of wheat bran extract containing arabinoxylan oligosaccharides on gastrointestinal parameters in healthy preadolescent children. J Pediatr Gastroenterol Nutr 2014 May; 58(5):647-53. doi: 10.1097/MPG.0000000000000285 PMID: 24368315.
25. Levey AS, Coresh J, Greene T, Stevens LA, Zhang YL, Hendriksen S, et al. Using standardized serum creatinine values in the modification of diet in renal disease study equation for estimating glomerular filtration rate. Ann Intern Med 2006 Aug 15; 145(4):247-54. PMID: 16908915.
26. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985 Jul; 28(7):412-9. PMID: 3899825.
27. Salmean YA, Segal MS, Palii SP, Dahl WJ. Fiber Supplementation Lowers Plasma p-Cresol in Chronic Kidney Disease Patients. J Ren Nutr 2014 Nov 5; 25:316-20. doi: 10.1053/j.jrn.2014.09.002 PMID: 25446837.
28. Poesen R, Windey K, Neven E, Kuypers D, De Preter V, Augustijns P, et al. The Influence of CKD on Colonic Microbial Metabolism. J Am Soc Nephrol 2015 [Epub ahead of print].